http://www.fpnotebook.com/
Genital WartAka: Venereal Wart, Condyloma acuminata, Genital HPV, Genital Human Papillomavirus
- See Also
- Verruca plana (Flat wart)
- Verruca Vulgaris (Common Wart)
- Verrucae plantaris (Plantar Wart)
- Molluscum Contagiosum
- Pathophysiology
- Human papillomavirus (HPV) infection of abraded skin
- HPV Types 6 and 11 most common visible types
- Rarely associated with invasive squamous cell cancer
- HPV Types 16 and 18 most aggressive
- Associated with cervical and anal dysplasia
- Other type associated with SCC: 31, 33, 35
- Epidemiology
- Prevalence
- Affects 15-40% of sexually active adults
- Present in 20 Million U.S. adults
- Sexually Transmitted
- Evaluate for other STDs if present
- Penile warts confer 50% transfer risk to cervix
- Incubation period
- Four weeks to more than a year after exposure
- Pathophysiology
- Human Papilloma Virus types 16, 18
- Human Papilloma Virus types 30,31, 34, 35, 39, 48
- Signs
- Characteristics
- Flesh colored exophytic lesions on genitalia
- Variable appearance
- Small, soft, fleshy Papules or
- Larger cauliflower-like or vegetating masses
- Accentuated by:
- Acetic acid (3-5%) or white vinegar
- Not all acetowhite lesions are warts
- Plain water soaks for 10 minutes
- Distribution
- Penis and scrotum, vulva, perineum, and perianal skin
- May spread to urethra and bladder
- Intra-anal warts may result
- May result in Hematuria
- Differential Diagnosis
- Molluscum Contagiosum
- Condyloma lata
- Fibroepithelioma
- Pearly penile Papule
- Squamous Cell Carcinoma
- Bowen's Disease
- Evaluation
- All women with HPV should undergo Colposcopy
- Direct association with Cervical Cancer
- Labs: Biopsy Indications
- Uncertain diagnosis
- Immunocompromised status
- Refractory to standard therapy
- Pigmented, indurated, fixed or ulcerated warts
- High risk for HPV-related malignancy
- See prognosis below
- Management: Overall treatment strategy
- Non-Keratinized Warts
- First line: Podofilox or Imiquimod
- Alternative: Cryotherapy
- Refractory: Podophyllin, TCA, ablation
- Keratinized warts
- First line
- Warts <10 mm: Cryotherapy
- Warts >10 mm: Surgical excision (or if persistent)
- Adjunctive: Imiquimod applied as pretreatment
- Warts on mucosal surface (Vagina, cervix, anal)
- First line: Cryotherapy
- Alternative: Trichloroacetic Acid
- Pregnancy
- Indications for HPV treatment in pregnancy
- Treat only to minimize neonatal HPV exposure
- Contraindicated medications
- Absolute contraindications
- Avoid Podophyllin, Podofilox, and fluorouracil
- Relative contraindications
- Imiquimod is not FDA approved
- Agents with relative safety for use in pregnancy
- Trichloroacetic acid
- Cryotherapy
- Surgical excision
- Electrocautery
- Subclinical warts
- General HPV screening is not recommended
- Reference
- Kodner (2004) Am Fam Physician 70:2335
- Management: Topical agents applied by patient
- Podofilox (Condylox) 0.5% solution or gel
- Podophyllotoxin extract applied to wart by patient
- Do not use for mucosal lesions
- Avoid on perianal, rectal, urethral, vaginal warts
- Imiquimod cream 5% (Aldara)
- Preferred option among many gynecologists
- Do not use on mucous membranes
- Management: Physician applied agents
- Podophyllin 10-25% in tincture of Benzoin
- Apply to each wart up to once weekly; allow to dry.
- Trichloroacetic acid (TCA) 60-90% solution
- Apply to each wart up to once weekly; allow to dry.
- If excessive application to normal skin
- Clean skin with liquid soap or Sodium Bicarbonate
- Management: Ablation
- Cryotherapy
- Apply to each wart up to once every 1-2 weeks
- Surgical excision to dermal-epidermal junction
- Risk of scarring if excision too deep
- Excision Techniques
- Electrosurgical (ED&C)
- Shave excision
- LEEP
- Carbon Dioxide laser (CO2 Laser)
- Use cautiously to avoid scarring
- May be used on mucosal lesions (vagina, urethra)
- Used by specialists
- Management: Agents for refractory warts (specialist use)
- Intralesional alpha interferon
- Topical alpha interferon
- Topical 5-FU 2% Solution
- No longer recommended due to adverse effects
- Prognosis
- Response to topical agents mixed
- Response in 60-70% of patients
- Recurrence in at least 20-30%
- No absolute cure
- Warts can be removed, but virus may not be eradicated
- HPV-related malignancy risk factors
- Chronic genital warts
- Tobacco abuse
- Cervical Dysplasia history
- High risk HPV-type (especially HPV 16 and 18)
- Complications: Cancers related to HPV Infection as STD
- Cervical Cancer
- Anal cancer
- Vulvar Cancer
- Vaginal cancer
- Penile cancer
- Oral and pharyngeal cancer
Anogenital venereal warts (C0009663)
|
|---|
| Definition (MSH) | Sexually transmitted form of anogenital warty growth caused by the human papillomaviruses. |
| Definition (CSP) | small, pointed papilloma of viral origin, usually occurring on the skin or mucous surface of the external genitalia or perianal region. |
| Definition (NCI) | (kahn-dih-LO-ma-ta a-kyoo-mih-NA-ta) Genital warts caused by certain human papillomaviruses (HPVs). |
| Concepts | Disease or Syndrome (T047)
|
| ICD9 | 078.11, 078.19 |
| English | Anogenital venereal warts, Anogenital wart, Anogenital warts, Condyloma Accuminata, CONDYLOMA ACUMINATA, CONDYLOMA ACUMINATUM, Condylomata Acuminata, Condylomata acuminatum, Genital Wart, Genital warts, Venereal wart, Venereal warts, Verruca acuminata |
| Spanish | condiloma acuminado, verruga acuminada, verruga anogenital, verruga genital, verruga venérea, verruga venerea, verrugas venéreas, verrugas venereas |
| Credits | Derived from the NIH UMLS (Unified Medical Language System)
|
Navigation Tree